Prostate News Archive
11-Oct-2006
Obesity may hamper prostate cancer detection: study (Reuters via Yahoo! News)
Obese men have lower levels of a protein used to screen for prostate cancer risk, U.S. researchers said on Monday in a study that shows doctors should take weight into account when determining a man's risk. High-Tech Radiation Boosts Prostate Cancer Survival (MedicineNet.com)
Title: High-Tech Radiation Boosts prostate Cancer Survival Category: Health News Created: 10/7/2006 2:05:00 AM Last Editorial Review: 10/9/2006 Obesity Affects Prostate Cancer Screens (Health Scout)
MONDAY, Oct. 9 (HealthDay News) -- Doctors need to be aware that obesity can affect prostate cancer screening test results, says a U.S. study. It found that obese white and black American men had lower levels of prostate surface antigen (PSA) and free PSA (fPSA) than men with normal body mass index (BMI). This suggests that an obese man with a slightly elevated PSA may be at higher risk for Healthy Cholesterol Levels Could Lower Prostate Cancer Risk (MedicineNet.com)
Title: Healthy Cholesterol Levels Could Lower Prostate Cancer Risk Category: Health News Created: 10/7/2006 2:05:00 AM Last Editorial Review: 10/9/2006 Obesity Affects Prostate Cancer Screens (HealthDay via Yahoo! News)
MONDAY, Oct. 9 (HealthDay News) -- Doctors need to be aware that obesity can affect prostate cancer screening test results, says a U.S. study. Quick Study | Does a common treatment for prostate cancer increase the risk of diabetes and heart disease? (Miami Herald)
THE QUESTION: Does a common treatment for prostate cancer increase the risk of diabetes and heart disease? THE CONTEXT: Drugs such as Lupron and Zoladex, known as gonadotropin-releasing hormone (GnRH) agonists, are a common treatment for advanced prostate cancer, and are becoming more popular for men with less advanced disease.
Back to Prostate News Archive
